Skip to main content
. Author manuscript; available in PMC: 2015 Aug 1.
Published in final edited form as: Rehabil Psychol. 2014 Jul 14;59(3):354–359. doi: 10.1037/a0037074

Table 1.

Demographics and Disease Information, n=405. PROMIS Profile 29, v. 1 and the Neuro-QOL scales were used to measure depressive symptoms, anxiety, fatigue, sleep disturbance, pain interference, social function and perceived cognition.

Variable Mean (SD) or % (n)
Age 52.68 (12.91)
Sex, % female 69.1% (280)
Education, Bachelor’s or higher 38.0% (154)
Income >$40,000 51.8% (210)
Relationship Status
 Married/Civil Union 60.2% (244)
 Long-term relationship 9.9% (40)
 Divorced/Single/Separated/Widowed 28.4% (115)
Race/Ethnicity
 Caucasian 92.6% (375)
 African American 2.0% (8)
 Hispanic 2.0% (8)
 Asian or Pacific Islander 0.7% (3)
 Native American 0.7% (3)
 Other/did not answer 2.9% (12)
Currently employed 29.4% (119)
Has health insurance coverage 96.3% (390)
 Medicaid 16.3% (66)
 Medicare 44.2% (179)
 Private Insurance 64.4% (261)
MS Type
 Relapsing/Remitting 58.8% (238)
 Primary Progressive 11.1% (45)
 Secondary Progressive 20.0% (81)
 Progressive Relapsing 1.0% (4)
Time since MS diagnosis, years 14.72 (9.70)
Depressive Symptoms 52.69 (9.77)
Anxiety 52.82 (9.26)
Fatigue 59.09 (9.34)
Sleep Disturbance 52.47 (9.46)
Pain Interference 56.25 (10.05)
Social Function 44.24 (8.57)
Perceived Cognition, Executive Function 42.38 (9.03)
Perceived Cognition, General 39.67 (9.49)